Valdecoxib recovers the lipid composition, order and dynamics in colon cancer cell lines independent of COX-2 expression

被引：0
|
作者：
Genc, Aysun Inan [1 ]
Gok, Seher [1 ]
Banerjee, Sreeparna [1 ]
Severcan, Feride [1 ]
机构：
[1] Middle East Tech Univ, Biochem, Ankara, Turkey
来源：
TOXICOLOGY LETTERS | 2017年 / 280卷
关键词：
D O I：
10.1016/j.toxlet.2017.07.619
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P-07-03-1
引用
收藏
页码：S224 / S224
页数：1
相关论文
共 50 条
  • [41] Effect of DHT on COX-2 expression in human hepatocellular carcinoma cell lines and relationship between AR and COX-2 in human hepatocellular carcinoma.
    Rahman, MA
    Ono, T
    Nagai, S
    Maeno, H
    Hira, E
    Onoda, T
    Yamanoi, A
    Kohno, H
    Nagasue, N
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1147S - 1148S
  • [42] The flavouring phytochemical 2-pentanone reduces prostaglandin production and COX-2 expression in colon cancer cells
    Pettersson, Jenny
    Karlsson, Pernilla Christina
    Goransson, Ulf
    Rafter, Joseph James
    Bohlin, Lars
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (03) : 534 - 537
  • [43] Chrysin induces apoptosis in different cyclooxygenase-2 (COX-2) expression human colon cancer cells
    Chen, J-N
    Wu, M-S
    Lien, G-S
    Chen, Y-F
    Cheng, Y-S
    Chen, Y-C
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A77 - A77
  • [44] COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status
    Asting, Annika Gustafsson
    Caren, Helena
    Andersson, Marianne
    Lonnroth, Christina
    Lagerstedt, Kristina
    Lundholm, Kent
    BMC CANCER, 2011, 11
  • [45] COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status
    Annika Gustafsson Asting
    Helena Carén
    Marianne Andersson
    Christina Lönnroth
    Kristina Lagerstedt
    Kent Lundholm
    BMC Cancer, 11
  • [46] COX-2 expression influences the prognostic effect of aspirin use after diagnosis in colon cancer patients
    Reimers, M. S.
    Bastiaannet, E.
    Van Eijk, R.
    Van Vlierberghe, R. L. P.
    Lemmens, V. E. P.
    Van Herk-Sukel, M. P. P.
    Van Wezel, T.
    Kuppen, P. J. K.
    Van de Velde, C. J. H.
    Liefers, G. J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S492 - S492
  • [47] The effect of combined treatment with COX-2 inhibitor and EGFR inhibitor in lung cancer cell lines
    Kim, H. R.
    Kim, N. R.
    Jeong, E. H.
    Lee, T. G.
    Kim, S. Y.
    Kim, C. H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S612 - S612
  • [48] COX-2 Expression and Opposite Growth Effect of N-3 and-6 PUFAs in Pancreatic Cancer Cell Lines
    Satake, M.
    Kuroda, N.
    Uyama, N.
    Hirano, T.
    Okada, T.
    Takahashi, M.
    Eibl, G.
    Go, V. L. W.
    Fujimoto, J.
    PANCREAS, 2009, 38 (08) : 1043 - 1043
  • [49] Madhuca indica Inhibits Breast Cancer Cell Proliferation by Modulating COX-2 Expression
    Ghosh, Paramita
    Mitra, Debarpan
    Mitra, Sreyashi
    Ray, Sudipta
    Banerjee, Samir
    Murmu, Nabendu
    CURRENT MOLECULAR MEDICINE, 2018, 18 (07) : 459 - 474
  • [50] The COX-2 inhibitor, celecoxib, inhibits differentially the cellular growth of ovarian, prostate and colon carcinoma cell lines independent of p53 status.
    Vital-Reyes, V
    Rodriguez-Burford, C
    Oelschlager, DK
    Suarez-Cuervo, C
    Manne, U
    Grizzle, WE
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1885S - 1885S
12345